Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Decoy Therapeutics Inc (DCOY) had Pre-Tax Income of $-2.22M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.22M |
|
-- |
|
-- |
|
$2.28M |
|
$-2.28M |
|
$0.06M |
|
|
Pre-Tax Income |
$-2.22M |
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.28M |
|
$-2.28M |
|
0.53M |
|
0.53M |
|
$-4.18 |
|
$-4.18 |
|
| Balance Sheet Financials | |
$8.36M |
|
$0.04M |
|
$0.07M |
|
$8.42M |
|
$4.55M |
|
-- |
|
-- |
|
$4.55M |
|
$3.88M |
|
$3.88M |
|
$3.88M |
|
0.53M |
|
| Cash Flow Statement Financials | |
$-2.89M |
|
-- |
|
-- |
|
$10.71M |
|
$7.82M |
|
$-2.89M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-57.37% |
|
-57.37% |
|
-26.41% |
|
-57.37% |
|
$7.29 |
|
$-5.43 |
|
$-5.43 |
|